Individualized concurrent chemotherapy by pretreatment plasma Epstein-Barr viral DNA in II-III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort.
Cancer Med
; 8(9): 4214-4225, 2019 08.
Article
in En
| MEDLINE
| ID: mdl-31210417
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
DNA, Viral
/
Nasopharyngeal Neoplasms
/
Herpesvirus 4, Human
/
Epstein-Barr Virus Infections
/
Propensity Score
/
Nasopharyngeal Carcinoma
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Med
Year:
2019
Type:
Article